Xynomic Pharmaceuticals Competitors and Similar CompaniesClear all
Xynomic Pharmaceuticals's competitors and similar companies include Omeros, Halozyme Therapeutics, Puma Biotechnology and Spectrum Pharmaceuticals.
 Xynomic Pharmaceuticals Xynomic Pharmaceuticals is a clinical-stage oncology therapeutics biopharmaceutical company developing oncology drugs. |  Omeros Omeros Corporation is a biopharmaceutical company developing products focused on inflammation and central nervous system disorders as well as immune-related diseases, including cancers. |  Halozyme Therapeutics Halozyme Therapeutics is a biotechnology company focused on developing and commercializing cancer therapies that target the tumor microenvironment. |  Puma Biotechnology Puma Biotechnology acquires and develops innovative products for the treatment of various forms of cancer. |  Spectrum Pharmaceuticals Spectrum Pharmaceuticals is a biotechnology company developing drugs to treat oncology and hematology. | |
Founding Date | Founding Date 2016 | Founding Date 1994 | Founding Date 1998 | Founding Date 2010 | Founding Date 2002 |
Type | Type Public | Type Public | Type Public | Type Public | Type Public |
Tags | |||||
Locations | Locations Dover, US HQ Poway, US | Locations Seattle, US HQ | Locations San Diego, US HQ | Locations Los Angeles, US HQ | Locations Henderson, US HQ Irvine, US |
Employees | Employees 25 | Employees 1968% decrease | Employees 373157% increase | Employees 27214% decrease | Employees 14638% decrease |
Valuation ($) | Valuation ($) 102.7 m | Valuation ($) 248.6 m | Valuation ($) 6.4 b | Valuation ($) 136.8 m | Valuation ($) 211.4 m |
Financial | |||||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) N/A | Revenue (est.) $1.4b (FY, 2025) | Revenue (est.) $228.4m (FY, 2025) | Revenue (est.) $10.1m (FY, 2022) |
Cost of goods | Cost of goods N/A | Cost of goods N/A | Cost of goods $228.8m (FY, 2025) | Cost of goods $58.2m (FY, 2025) | Cost of goods N/A |
Gross profit | Gross profit N/A | Gross profit N/A | Gross profit $1.2b (FY, 2025) | Gross profit $170.2m (FY, 2025) | Gross profit N/A |
Net income | Net income ($25.1m) (FY, 2019) | Net income ($3.4m) (FY, 2025) | Net income $316.9m (FY, 2025) | Net income N/A | Net income ($75.4m) (FY, 2022) |
Operating ⚠ | |||||
Patents (US) | Patents (US) N/A | Patents (US) 80 (FY, 2021) | Patents (US) 43 (FY, 2020) | Patents (US) N/A | Patents (US) N/A |
Phase I Trials Products | Phase I Trials Products N/A | Phase I Trials Products 3 (FY, 2021) | Phase I Trials Products 10 (FY, 2020) | Phase I Trials Products N/A | Phase I Trials Products 3 (FY, 2016) |
Phase II Trials Products | Phase II Trials Products N/A | Phase II Trials Products 2 (FY, 2021) | Phase II Trials Products 1 (FY, 2020) | Phase II Trials Products N/A | Phase II Trials Products 1 (FY, 2016) |
Phase III Trials Products | Phase III Trials Products N/A | Phase III Trials Products 2 (FY, 2021) | Phase III Trials Products 8 (FY, 2020) | Phase III Trials Products N/A | Phase III Trials Products 3 (FY, 2016) |
Preclinical Phase Products | Preclinical Phase Products N/A | Preclinical Phase Products 5 (FY, 2021) | Preclinical Phase Products 2 (FY, 2018) | Preclinical Phase Products N/A | Preclinical Phase Products N/A |
Funding | |||||
Total funding raised | Total funding raised $ 4.8m | Total funding raised $ 354.8m | Total funding raised $ 171.9m | Total funding raised $ 172m | Total funding raised $ 3m |
For sources of this data, please see the company profile
View Company Profiles
Omeros
HQ
Seattle, US
Employees
196↓ 8% decrease
Omeros Corporation is a biopharmaceutical company developing products focused on inflammation and central nervous system disorders as well as immune-related diseases, including cancers.
View companyHalozyme Therapeutics
HQ
San Diego, US
Employees
373
Halozyme Therapeutics is a biotechnology company focused on developing and commercializing cancer therapies that target the tumor microenvironment.
View companyPuma Biotechnology
HQ
Los Angeles, US
Employees
272↓ 14% decrease
Puma Biotechnology acquires and develops innovative products for the treatment of various forms of cancer.
View companySpectrum Pharmaceuticals
HQ
Henderson, US
Employees
146↓ 38% decrease
Spectrum Pharmaceuticals is a biotechnology company developing drugs to treat oncology and hematology.
View company